Company Filing History:
Years Active: 2003
Title: Jan Strombom - Innovator in Pharmaceutical Formulation
Introduction
Jan Strombom is a notable inventor based in Vattholma, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance drug delivery and efficacy. His work focuses on addressing medical conditions such as overactive bladder and gastrointestinal disorders.
Latest Patents
Jan Strombom holds a patent for a pharmaceutical formulation that contains tolterodine or a related compound. This formulation is designed to exhibit a controlled in vitro release of the active ingredient in phosphate buffer at pH 6.8, achieving not less than about 80% release after 18 hours. Furthermore, after oral administration, it is capable of maintaining a substantially constant serum level of the active moiety for 24 hours. This innovation is particularly useful for treating overactive bladder and gastrointestinal disorders.
Career Highlights
Jan Strombom is associated with Pharmacia AB, where he has contributed to various research and development projects. His expertise in pharmaceutical formulations has positioned him as a key player in the industry, focusing on improving patient outcomes through innovative drug delivery systems.
Collaborations
Jan has collaborated with notable colleagues such as Lisbeth Nilvebrant and Bengt Hallen. These partnerships have fostered a collaborative environment that enhances the development of effective pharmaceutical solutions.
Conclusion
Jan Strombom's contributions to pharmaceutical formulations demonstrate his commitment to innovation in healthcare. His work continues to impact the treatment of various medical conditions, showcasing the importance of research and development in the pharmaceutical industry.